Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04880070 · ClinicalTrials.gov registry record · NA
Post-Market Clinical Follow Up Study to Collect Additional Data and Imaging
A NA study of Connective Tissue Defect, sponsored by Cynosure.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
- 1
- Study location
NCT04880070: Completed NA study of Connective Tissue Defect, sponsored by Cynosure.
NCT04880070 is a NA study of Connective Tissue Defect that has completed, run by Cynosure. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04880070, a NA study of Connective Tissue Defect, has completed, sponsored by Cynosure.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, open label, multi-center clinical study to collect additional data and imaging for the ViaSure device.The intended use of the ViaSure device used in this study is to assess the usability and tissue response to shock wave treatment.
Primary Outcome
Subjects had their gene expression relative to their own baseline samples analyzed using nSolver 4.0 software, and this was done 14 days post treatment.
Conditions Studied
Interventions
- DEVICE Shockwave Treatment
Study Locations (1)
Massachusetts
- Cynosure, Inc. - Westford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-03-12 |
| Est. Completion | 2021-05-11 |
| Phase | NA |
What the finished NCT04880070 record still lists
NCT04880070 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 1 condition, with Connective Tissue Defect appearing as the primary indexed condition, and to 1 intervention - of which Shockwave Treatment is the first listed.
NCT04880070 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT04880070 about?
NCT04880070 is a clinical study titled "Post-Market Clinical Follow Up Study to Collect Additional Data and Imaging". This is a prospective, open label, multi-center clinical study to collect additional data and imaging for the ViaSure device.The intended use of the ViaSure device used in this study is to assess the usability and tissue response to shock wave treatment.
What is the current status of trial NCT04880070?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2021-03-12. Estimated completion is 2021-05-11.
What conditions does trial NCT04880070 study?
This clinical trial studies the following conditions: Connective Tissue Defect.
What interventions are being tested in trial NCT04880070?
The interventions under investigation include: Shockwave Treatment (DEVICE).
Who is sponsoring clinical trial NCT04880070?
This trial is sponsored by Cynosure, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04880070 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04880070's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI